Evidence map›Paper›PMID 30989168›Full record

ArticleChemical senses2019

Effects of Tokishakuyakusan on Regeneration of Murine Olfactory Neurons In Vivo and In Vitro.

Takuya Noda, Hideaki Shiga, Kentaro Yamada, Masayuki Harita, Yukari Nakamura, Tomoko Ishikura, Masami Kumai, Zenji Kawakami, Atsushi Kaneko, Toshihisa Hatta and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Chemical senses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Therapeutic Effects ofLife (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Olfactory Function and Olfactory Disorders.Laryngo- rhino- otologie · 2023
    Article
  10. Article
  11. Levistolide A Attenuates Alzheimer's Pathology Through Activation of the PPARγ Pathway.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Takuya NodaDepartment of Otorhinolaryngology, Kanazawa Medical University, Ishikawa, Japan.
Hideaki ShigaDepartment of Otorhinolaryngology, Kanazawa Medical University, Ishikawa, Japan.
Kentaro YamadaDepartment of Otorhinolaryngology, Kanazawa Medical University, Ishikawa, Japan.
Masayuki HaritaDepartment of Otorhinolaryngology, Kanazawa Medical University, Ishikawa, Japan.
Yukari NakamuraDepartment of Otorhinolaryngology, Kanazawa Medical University, Ishikawa, Japan.
Tomoko IshikuraDepartment of Otorhinolaryngology, Kanazawa Medical University, Ishikawa, Japan.
Masami KumaiDepartment of Otorhinolaryngology, Kanazawa Medical University, Ishikawa, Japan.
Zenji KawakamiTsumura Kampo Research Laboratories, Tsumura & Co., Ibaraki, Japan.
Atsushi KanekoTsumura Kampo Research Laboratories, Tsumura & Co., Ibaraki, Japan.
Toshihisa HattaDepartment Anatomy I, Kanazawa Medical University, Ishikawa, Japan.
Hiromi Sakata-HagaDepartment Anatomy I, Kanazawa Medical University, Ishikawa, Japan.
Hiroki ShimadaDepartment Anatomy I, Kanazawa Medical University, Ishikawa, Japan.
Takaki MiwaDepartment of Otorhinolaryngology, Kanazawa Medical University, Ishikawa, Japan.
Kanazawa Medical University · JPTsumura Research Institute (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-upper respiratory tract infection related olfactory dysfunction typically occurs due to neural damage after an upper respiratory tract infection associated with a common cold or influenza. At present, Tokishakuyakusan, a Japanese traditional Kampo medicine, has been found to be effective for post-viral olfactory dysfunction. However, the pharmacodynamics of Tokishakuyakusan in the treatment of post-viral olfactory dysfunction remains unresolved. We investigated the effects of Tokishakuyakusan on the regeneration of olfactory neurons and expression of nerve growth factor (NGF) in neural systems, using in vivo murine studies and in vitro cell culture studies. Eight-week-old BALB/C female mice were fed a pellet diet with or without Tokishakuyakusan. Degeneration of cells in olfactory epithelium was induced by intraperitoneal methimazole injection. Regeneration of olfactory neurons was observed by histological and immunohistochemical procedures. NGF expression in the olfactory bulb was measured by enzyme-linked immunosorbent assay. NGF gene and protein expression were measured using rat primary cultured astrocytes by real-time polymerase chain reaction and enzyme-linked immunosorbent assay. We found that olfactory marker protein, Ki-67, and NGF were more highly expressed in the olfactory epithelium during the regeneration period in mice receiving Tokishakuyakusan. In cultured astrocytes, Tokishakuyakusan as well as its individual components, Atractylodes lancea rhizome and Japanese angelica root, increased NGF expression. Screening assays revealed that NGF production was increased by atractylodin and levistolide A, which are ingredients in Atractylodes lancea rhizome and Japanese angelica root, respectively. These results suggest that Tokishakuyakusan promotes regeneration of olfactory neurons by increasing NGF expression in the olfactory bulb.

Indexed as

Administration, OralAnimalsAstrocytesCells, CulturedDrugs, Chinese HerbalEpitheliumFemaleInjections, IntraperitonealMethimazoleMiceMice, Inbred BALB CNerve Growth FactorsNeuronsOlfactory BulbDrugs, Chinese HerbalMethimazoleNerve Growth Factorstoki-shakuyaku-sanKamponerve growth factorolfactory epitheliumpost-upper respiratory tract infection related olfactory dysfunction

Identifiers

PMID30989168
PMCPMC6538963
OpenAlexW2939069481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.